The Journal of Experimental Medicine
StemCell Technologies
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 28 February 2000.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kennedy, M. K.
Right arrow Articles by Peschon, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kennedy, M. K.
Right arrow Articles by Peschon, J. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© The Rockefeller University Press, 0022-1007/2000/3/771/ $5.00
The Journal of Experimental Medicine, Volume 191, Number 5, March 6, 2000 771-780


Original Article

Reversible Defects in Natural Killer and Memory CD8 T Cell Lineages in Interleukin 15–deficient Mice

Mary K. Kennedya, Moira Glaccuma, Sandra N. Browna, Eric A. Butza, Joanne L. Vineya, Monica Embersb, Naoto Matsukib, Keith Charriera, Lisa Sedgera, Cynthia R. Willisa, Kenneth Brasela, Philip J. Morrisseya, Kim Stockinga, JoAnn C. L. Schuha, Sebastian Joyceb, and Jacques J. Peschona
a Immunex Corporation, Seattle, Washington 98101
b Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033

Correspondence to: Jacques J. Peschon, Immunex Corporation, 51 University St., Seattle, WA 98101-2936. Tel:206-587-0430 Fax:206-624-7496 E-mail:peschon{at}immunex.com.

Released online: 28 February 2000

C57BL/6 mice genetically deficient in interleukin 15 (IL-15-/- mice) were generated by gene targeting. IL-15-/- mice displayed marked reductions in numbers of thymic and peripheral natural killer (NK) T cells, memory phenotype CD8+ T cells, and distinct subpopulations of intestinal intraepithelial lymphocytes (IELs). The reduction but not absence of these populations in IL-15-/- mice likely reflects an important role for IL-15 for expansion and/or survival of these cells. IL-15-/- mice lacked NK cells, as assessed by both immunophenotyping and functional criteria, indicating an obligate role for IL-15 in the development and functional maturation of NK cells. Specific defects associated with IL-15 deficiency were reversed by in vivo administration of exogenous IL-15. Despite their immunological defects, IL-15-/- mice remained healthy when maintained under specific pathogen-free conditions. However, IL-15-/- mice are likely to have compromised host defense responses to various pathogens, as they were unable to mount a protective response to challenge with vaccinia virus. These data reveal critical roles for IL-15 in the development of specific lymphoid lineages. Moreover, the ability to rescue lymphoid defects in IL-15-/- mice by IL-15 administration represents a powerful means by which to further elucidate the biological roles of this cytokine.

Key Words: interleukin 15, knockout mice, natural killer cells, CD8+ T lymphocytes, immunologic memory


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS